Swiss Life Asset Management Trims Johnson & Johnson Stake

Institutional investor reduces holdings in healthcare giant by 2%

Mar. 21, 2026 at 9:19am

Got story updates? Submit your updates here. ›

Swiss Life Asset Management Ltd. trimmed its stake in Johnson & Johnson (NYSE: JNJ) by 2.0% during the 3rd quarter, according to a disclosure filed with the Securities and Exchange Commission. The institutional investor now owns 1,268,409 shares of the company's stock, valued at around $235,188,000.

Why it matters

Johnson & Johnson is a major pharmaceutical and healthcare company, and changes in institutional ownership can signal shifts in investor sentiment around the stock. Swiss Life Asset Management's decision to reduce its position, even slightly, is noteworthy and may reflect broader market trends or company-specific factors.

The details

According to the filing, Swiss Life Asset Management sold 26,035 shares of Johnson & Johnson stock during the 3rd quarter. The firm now owns approximately 0.05% of the company's outstanding shares. Johnson & Johnson accounts for 1.2% of Swiss Life Asset Management's overall portfolio, making it the 12th largest holding.

  • The share sale occurred during the 3rd quarter of the year.

The players

Swiss Life Asset Management Ltd

An institutional investment firm that manages over $300 billion in assets globally.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

This transaction suggests Swiss Life Asset Management is taking a more cautious stance on Johnson & Johnson, potentially due to market conditions or company-specific factors. However, the firm still maintains a sizable position in the healthcare giant, indicating ongoing confidence in the company's long-term prospects.